Hyperprolactinemia and the multiple endocrine adenomatosis type 1 (MEA-1) syndrome

Editorial

J H Levine et al. Arch Intern Med. 1978 Dec.

. 1978 Dec;138(12):1777-8.

No abstract available

Similar articles

Hyperprolactinemia in multiple endocrine adenomatosis, type 1.
Carlson HE, Levine GA, Goldberg NJ, Hershman JM. Carlson HE, et al. Arch Intern Med. 1978 Dec;138(12):1807-8. Arch Intern Med. 1978. PMID: 31144
Dopamine control of prolactin secretion in multiple endocrine neoplasia type I.
Dornan J, O'Leary JG, Farid NR. Dornan J, et al. Clin Invest Med. 1984;7(3):161-4. Clin Invest Med. 1984. PMID: 6151431
[Clinicopathologic conference. Prolactinoma and hyperaldosteronism in a 55-year-old male: variant of multiple endocrine adenomatosis (MEA) type I?].
Gieshoff B, Benker G, Windeck R, Reinwein D. Gieshoff B, et al. Med Klin (Munich). 1987 May 15;82(11):394-9. Med Klin (Munich). 1987. PMID: 2885732 German. No abstract available.
[Multiple endocrine adenomatosis. Type I (author's transl)].
Hashizume K, Onaya T, Yamada T. Hashizume K, et al. Nihon Rinsho. 1976 Oct 10;34(10):2994-3002. Nihon Rinsho. 1976. PMID: 12382 Review. Japanese. No abstract available.
[Multiple endocrine neoplasia type I. Review and presentation of the study group of multiple endocrine neoplasia type I (GENEM I)].
Saint-André JP, Berger-Dutrieux N, Le Bodic MF, de Micco C, Trouillas J. Saint-André JP, et al. Arch Anat Cytol Pathol. 1994;42(2):77-82. Arch Anat Cytol Pathol. 1994. PMID: 7811118 Review. French.